[1]
Samar Minallah et al. 2025. Impact of Filgrastim Versus Pegfilgrastim on Hospital Stay and Mortality Among Chemotherapy-Induced Febrile Neutropenia Patients. Journal of Health, Wellness and Community Research. (May 2025), e191. DOI:https://doi.org/10.61919/dyepxp89.